StockStory favors Interface, questions Etsy and 10x Genomics despite positive free cash flow

StockStory said on May 13, 2026, that Interface (TILE) is its preferred cash-generating stock among three reviewed companies, while raising concerns about Etsy (ETSY) and 10x Genomics (TXG) despite their positive free cash flow margins. Etsy reported a trailing 12-month free cash flow margin of 23.5% and traded at $64.53, or 11.6 times forward EV/EBITDA. 10x Genomics posted a 19.1% trailing 12-month free cash flow margin and traded at $21.65, or 4.6 times forward price-to-sales. Interface had an 8.5% trailing 12-month free cash flow margin and traded at $29.64, implying a 1.1 times trailing 12-month price-to-sales ratio. StockStory said cash generation alone does not make a stock attractive and emphasized whether companies can convert cash flow into shareholder value.